Your browser doesn't support javascript.
loading
Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis.
Almeida, Deepak; Ioerger, Thomas; Tyagi, Sandeep; Li, Si-Yang; Mdluli, Khisimuzi; Andries, Koen; Grosset, Jacques; Sacchettini, Jim; Nuermberger, Eric.
Afiliação
  • Almeida D; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Ioerger T; Department of Computer Science, Texas A&M University, College Station, Texas, USA.
  • Tyagi S; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Li SY; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Mdluli K; Global Alliance for TB Drug Development, New York, New York, USA.
  • Andries K; Janssen Pharmaceutica, Beerse, Belgium.
  • Grosset J; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sacchettini J; Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas.
  • Nuermberger E; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA enuermb@jhmi.edu.
Antimicrob Agents Chemother ; 60(8): 4590-9, 2016 08.
Article em En | MEDLINE | ID: mdl-27185800

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Plantas_medicinales Assunto principal: Clofazimina / Diarilquinolinas / Mycobacterium tuberculosis / Antituberculosos Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Plantas_medicinales Assunto principal: Clofazimina / Diarilquinolinas / Mycobacterium tuberculosis / Antituberculosos Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos